Compulsory licensing for expensive medicines
Research output: Book/Report › Report › Commissioned › peer-review
Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.
Original language | English |
---|
Place of Publication | Brussels |
---|---|
Publisher | Belgian Health Care Knowledge Centre (KCE). |
Number of pages | 200 |
Publication status | Published - 14 Jun 2022 |
- Faculty of Law - Patents, Data, compulsory licensing, expensive medicine
Research areas
Links
- https://kce.fgov.be/en/compulsory-licensing-for-expensive-medicines
Final published version
ID: 310249981